Agilent Technologies, Inc. (A | DoD: +0.33% | YTD: -10.67% | LargeCap: 32.1B)

• Profile: Provider of application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide
• Reporting: Agilent Reports Third-Quarter Fiscal Year 2025 Financial Results (Full Text)

Qiagen N.V. (QGEN | DoD: -1.78% | YTD: +8.35% | MidCap: 9.8B)

• Profile: Provides sample to insight solutions that transform biological samples into molecular insights
• Stock Offering: QIAGEN N.V. Launches Non-US Offering of Net Share Settled Convertible Bonds (Full Text)

The Cooper Companies, Inc. (COO | DoD: +0.60% | YTD: -18.26% | MidCap: 13.3B)

• Profile: A leading global medical device company
• Reporting: CooperCompanies Announces Third Quarter 2025 Results (Full Text)

Zentek Ltd. (ZTEK | DoD: +6.53% | YTD: -30.37% | SmallCap: 159M)

• Profile: Engages in the research and development of graphene and related nanomaterials
• Stock Offering: Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (Full Text)

IQVIA Holdings Inc. (IQV | DoD: +0.55% | YTD: -3.24% | MidCap: 24.4B)

• Profile: Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries
• Collaboration: IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies (Full Text)

Natera, Inc. (NTRA | DoD: -1.61% | YTD: +1.52% | MidCap: 21.9B)

• Profile: A diagnostics company, provides molecular testing services worldwide
• Clinical: Signatera™ Test Selected for NRG-Sponsored Phase III ARCHER Trial in Bladder Cancer (Full Text)

Veracyte, Inc. (VCYT | DoD: -1.58% | YTD: -29.25% | MidCap: 2.1B)

• Profile: Operates as a diagnostics company 
• Clinical: Veracyte Announces New Study Published in Cell Shows that Decipher Prostate Test Predicts Chemotherapy Benefit in Patients with Metastatic Prostate Cancer (Full Text)

Catheter Precision, Inc. (VTAK | DoD: -12.19% | YTD: -71.29% | SmallCap: 2M)

• Profile: A US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market
• Product: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues (Full Text)

Stereotaxis, Inc. (STXS | DoD: +3.24% | YTD: +25.33% | SmallCap: 193M)

• Profile: A pioneer and global leader in surgical robotics for minimally invasive endovascular intervention
• Product: Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025 (Full Text)

Thermo Fisher Scientific Inc. (TMO | DoD: -0.07% | YTD: -6.42% | LargeCap: 148.8B)

• Profile: Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services
• Award: Thermo Fisher Scientific Secures R&D 100 Awards for Innovations Accelerating the Discovery and Development of Therapies (Full Text)

XWELL, Inc. (XWEL | DoD: -0.93% | YTD: -30.93% | SmallCap: 5M)

• Profile: Provides health and wellness services to travelers
• Product: XWELL Expands Florida Presence with Grand Opening of Waterford Lakes Wellness Center on September 5 (Full Text)

BioSig Technologies, Inc. (BSGM | DoD: -9.30% | YTD: +241.43% | SmallCap: 178M)

• Profile: A medical technology company delivering unprecedented accuracy and precision to intra-cardiac signal visualization
• Event: Streamex (BSGM) to Participate in the 5th Annual Needham Virtual Crypto 1x1 Conference on September 4th (Full Text)

Myriad Genetics, Inc. (MYGN | DoD: +2.07% | YTD: -56.07% | SmallCap: 423M)

• Profile: A molecular diagnostic testing and precision medicine company, develops and provides molecular tests
• Event: Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences (Full Text)

NeuroPace, Inc. (NPCE | DoD: -1.00% | YTD: -23.32% | SmallCap: 428M)

• Profile: Founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders
• Event: NeuroPace to Participate in Upcoming Healthcare Conferences (Full Text)

NovoCure Limited (NVCR | DoD: +0.68% | YTD: -60.29% | MidCap: 1.9B)

• Profile: A global oncology company working to extend survival in some of the most aggressive forms of cancer
• Event: Novocure Announces Upcoming Investor Events (Full Text)

Profound Medical Corp. (PROF | DoD: +0.33% | YTD: -42.78% | SmallCap: 165M)

• Profile: A commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue
• Event: Profound Medical to Participate in Lake Street's 9th Annual Best Ideas Growth Conference (Full Text)

Zimmer Biomet Holdings, Inc. (ZBH | DoD: -0.70% | YTD: +2.72% | MidCap: 18.3B)

• Profile: A global medical technology leader in the spinal and orthopedic therapy space
• Leadership Update: Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care (Full Text)